RHA dermal fillers
Commercial- Indications
- Aesthetic medicine
Company intelligence / Profile preview
Teoxane’s RHA® hyaluronic acid filler range and cosmeceutical products are commercially available in over 90 countries. Clinical results include validated improvements in skin hydration, reduction of oxidative stress markers by up to 27%, increased epidermal thickness by an average of 27% after use, and improved dermoepidermal junction integrity within days of application. The injectable fillers are widely used by aesthetic professionals globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Teoxane.